Regulatory considerations for preclinical development of anticancer drugs Joseph J. DeGeorgeChang-Ho AhnSatish C. Tripathi ORIGINAL ARTICLE Pages: 173 - 185
Abrogated energy-dependent uptake of cisplatin in a cisplatin-resistant subline of the human ovarian cancer cell line IGROV-1 Jianguo MaMarc MaliepaardJan H. M. Schellens ORIGINAL ARTICLE Pages: 186 - 192
Augmentation of hepatic doxorubicin extraction with extracorporeal filtration avoids the dose-dependent, nonlinear increase in AUC observed with systemic administration Marc G. SturgillDean E. BrennerDavid A. August ORIGINAL ARTICLE Pages: 193 - 200
Whole-body disposition and polyglutamate distribution of the GAR formyltransferase inhibitors LY309887 and lometrexol in mice: effect of low-folate diet Lillian L HabeckSylvia H. ChayLaurane G. Mendelsohn ORIGINAL ARTICLE Pages: 201 - 209
Alkylphosphocholines induce apoptosis in HL-60 and U-937 leukemic cells Spiro M. KonstantinovHansjörg EiblMartin R. Berger ORIGINAL ARTICLE Pages: 210 - 216
Activity of gemcitabine in non-small-cell lung cancer: results of the Japan gemcitabine group (A) phase II study Minoru TakadaShun-ichi NegoroMasahiro Fukuoka ORIGINAL ARTICLE Pages: 217 - 222
An inhibitor of glycinamide ribonucleotide formyltransferase is selectively cytotoxic to cells that lack a functional G1 checkpoint Cathy C. ZhangTheodore J. BoritzkiRobert C. Jackson ORIGINAL ARTICLE Pages: 223 - 228
Clinical effects and pharmacokinetics of the fusion protein PIXY321 in children receiving myelosuppressive chemotherapy Wayne L. FurmanJohn H. RodmanWilliam H. Meyer ORIGINAL ARTICLE Pages: 229 - 236
Characterization of acylfulvene histiospecific toxicity in human tumor cell lines Michael J. KelnerTrevor C. McMorrisRaymond Taetle ORIGINAL ARTICLE Pages: 237 - 242
A combination chemoendocrine therapy of mitoxantrone, doxifluridine, and medroxyprogesterone acetate for anthracycline-resistant advanced breast cancer Yuichi IinoTakao YokoeSeiichiro Kishi ORIGINAL ARTICLE Pages: 243 - 247
Sample handling for determination of free platinum in blood after cisplatin exposure Anders JohnssonHenrik BjörkTor Skärby SHORT COMMUNICATION Pages: 248 - 251
Piperazine derivatives of butyric acid as differentiating agents in human leukemic cells Reynald GilletP. JeannessonFrançois Pieri SHORT COMMUNICATION Pages: 252 - 255